BX Swiss TOP 30 CHF
1.253,26
PKT
+0,53
PKT
+0,04
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
26.01.17 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
26.01.17 | Novartis Underweight | Morgan Stanley | |
26.01.17 | Novartis Hold | Deutsche Bank AG | |
26.01.17 | UBS Neutral | Goldman Sachs Group Inc. | |
26.01.17 | UBS buy | Goldman Sachs Group Inc. | |
25.01.17 | UBS Buy | UBS AG | |
25.01.17 | Novartis Hold | S&P Capital IQ | |
25.01.17 | UBS Hold | Deutsche Bank AG | |
25.01.17 | UBS Hold | Deutsche Bank AG | |
25.01.17 | Nestlé buy | UBS AG | |
25.01.17 | Nestlé overweight | JP Morgan Chase & Co. | |
25.01.17 | Nestlé overweight | JP Morgan Chase & Co. | |
25.01.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
25.01.17 | Zurich Insurance Outperform | BNP PARIBAS | |
25.01.17 | Novartis Outperform | Bernstein Research | |
25.01.17 | Novartis buy | Baader Bank | |
24.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
24.01.17 | UBS buy | Baader Bank | |
24.01.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
24.01.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
24.01.17 | UBS buy | HSBC | |
23.01.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
23.01.17 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
23.01.17 | Roche overweight | JP Morgan Chase & Co. | |
23.01.17 | UBS Equal-Weight | Morgan Stanley | |
23.01.17 | UBS overweight | Morgan Stanley | |
23.01.17 | Nestlé overweight | Barclays Capital | |
20.01.17 | UBS Hold | Deutsche Bank AG | |
20.01.17 | Swiss Re Hold | Deutsche Bank AG | |
19.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
19.01.17 | Holcim buy | Deutsche Bank AG | |
18.01.17 | ABB (Asea Brown Boveri) Sell | Citigroup Corp. | |
18.01.17 | UBS buy | UBS AG | |
18.01.17 | Swiss Re Underperform | Jefferies & Company Inc. | |
17.01.17 | Nestlé buy | Deutsche Bank AG | |
17.01.17 | Givaudan buy | Deutsche Bank AG | |
16.01.17 | Swiss Re Underperform | Credit Suisse Group | |
16.01.17 | Nestlé buy | UBS AG | |
16.01.17 | Zurich Insurance Outperform | Credit Suisse Group | |
16.01.17 | Swiss Re Sell | UBS AG |